Insights from the RAY trial: treating relapsed mantle cell lymphoma patients
What can clonal evolution in chronic lymphocytic leukemia (CLL) tell us about outcomes?
Immunotherapy discussions at ASH 2017
Raúl Córdoba et al.
iwNHL 2016 highlights: CAR T-cell therapy, DLBCL and new technologies
Why do many MM patients relapse after being treated with targeted therapy?